Xcel Wealth Management LLC Sells 9,000 Shares of Celsius Holdings Inc. $CELH

Key Points

• Xcel Wealth Management LLC reduced its stake in Celsius Holdings Inc. by 37.8% during the second quarter, selling 9,000 shares to end up with 14,828 shares valued at $688,000.
• Major shareholder Deborah Desantis sold 100,000 shares for $4.75 million, while insider Paul H. Storey sold 7,500 shares for approximately $457,000, indicating notable insider selling activity.
• Analysts have raised their price targets for Celsius Holdings, with Mizuho increasing its target from $85 to $90 and others providing buy ratings, reflecting strong confidence in the company's performance amidst significant year-over-year revenue growth of 83.9%.

Xcel Wealth Management LLC decreased its holdings in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 37.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,828 shares of the company's stock after selling 9,000 shares during the period. Xcel Wealth Management LLC's holdings in Celsius were worth $688,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of CELH. Assenagon Asset Management S.A. lifted its position in Celsius by 9,579.6% during the second quarter. Assenagon Asset Management S.A. now owns 828,860 shares of the company's stock valued at $38,451,000 after purchasing an additional 820,297 shares in the last quarter. Fifth Third Bancorp raised its stake in shares of Celsius by 62.9% in the first quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after buying an additional 666 shares during the period. Polianta Ltd bought a new position in shares of Celsius in the second quarter worth about $1,428,000. GAMMA Investing LLC lifted its position in shares of Celsius by 4,164.4% during the 1st quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock valued at $2,604,000 after buying an additional 71,378 shares in the last quarter. Finally, Oppenheimer & Co. Inc. grew its stake in shares of Celsius by 14.0% during the 1st quarter. Oppenheimer & Co. Inc. now owns 9,760 shares of the company's stock valued at $348,000 after acquiring an additional 1,199 shares during the period. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Celsius

In other news, major shareholder Deborah Desantis sold 100,000 shares of the stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the transaction, the insider directly owned 17,717,770 shares in the company, valued at approximately $841,594,075. This represents a 0.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Paul H. Storey sold 7,500 shares of the business's stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $60.93, for a total transaction of $456,975.00. Following the completion of the sale, the insider owned 37,550 shares in the company, valued at $2,287,921.50. This represents a 16.65% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 860,667 shares of company stock worth $41,421,162 over the last three months. 2.55% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Mizuho raised their target price on shares of Celsius from $85.00 to $90.00 and gave the stock an "outperform" rating in a research note on Tuesday, September 2nd. The Goldman Sachs Group began coverage on shares of Celsius in a research note on Thursday, September 11th. They issued a "buy" rating and a $72.00 price objective for the company. UBS Group lifted their target price on shares of Celsius from $64.00 to $73.00 and gave the company a "buy" rating in a research note on Tuesday, September 2nd. Piper Sandler increased their price target on Celsius from $60.00 to $69.00 and gave the stock an "overweight" rating in a research note on Monday, September 8th. Finally, Stifel Nicolaus raised their price target on Celsius from $56.00 to $70.00 and gave the company a "buy" rating in a report on Tuesday, September 2nd. Eighteen equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Celsius has a consensus rating of "Moderate Buy" and an average price target of $61.95.

Celsius Stock Performance

Shares of NASDAQ CELH opened at $51.88 on Thursday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The company has a market cap of $13.38 billion, a P/E ratio of 140.22, a P/E/G ratio of 1.15 and a beta of 1.34. The firm's fifty day moving average is $53.73 and its two-hundred day moving average is $43.54. Celsius Holdings Inc. has a 52-week low of $21.10 and a 52-week high of $63.50.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.23 by $0.24. The business had revenue of $739.30 million during the quarter, compared to the consensus estimate of $632.13 million. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The business's revenue was up 83.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.28 EPS. As a group, analysts anticipate that Celsius Holdings Inc. will post 0.89 EPS for the current fiscal year.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.